Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1 Tadashi KumamotoFumito YamazakiYukiko Tsunematsu Special Article Open access 11 October 2021 Pages: 2161 - 2178
Palbociclib as an early-line treatment for Japanese patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: a review of clinical trial and real-world data Norikazu MasudaNobuyoshi KosakaMasakazu Toi Review Article Open access 26 October 2021 Pages: 2179 - 2193
Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients Linhui ZhuHuan LiQing Zhai Review Article Open access 09 October 2021 Pages: 2194 - 2204
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study Tomokazu AokiNaoki KagawaRyo Nishikawa Original Article Open access 29 September 2021 Pages: 2205 - 2215
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101) Masafumi YamaguchiHirohito TadaWest Japan Thoracic Oncology Group (WJTOG) Original Article 31 August 2021 Pages: 2216 - 2223
Assessment of button-type jejunostomy for nutritional management after esophagectomy in 201 cases Yoshitaka IshikawaKatsunori NishikawaToru Ikegami Original Article 31 August 2021 Pages: 2224 - 2228
The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancer Xia SunXianting HuangQiong Wang Original Article 24 October 2021 Pages: 2229 - 2236
Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study Il Tae SonJeong Yeon KimJong Wan Kim Original Article 28 August 2021 Pages: 2237 - 2245
Computed tomography-derived biomarker for predicting the treatment response to neoadjuvant chemoradiotherapy of rectal cancer Yoshihiro KurataKoichi HayanoHisahiro Matsubara Original Article 28 September 2021 Pages: 2246 - 2254
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases Mizuki NinomiyaYasunori EmiHiroyuki Kuwano Original Article 14 September 2021 Pages: 2255 - 2264
Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient Katsuki MiyazakiYuji MorineMitsuo Shimada Original Article 01 October 2021 Pages: 2265 - 2274
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience Masaki UchiharaMaki TaniokaKan Yonemori Original Article 01 September 2021 Pages: 2275 - 2281
Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis Bryan S. SquiresThomas J. QuinnM. Saada Jawad Original Article 24 August 2021 Pages: 2282 - 2294
Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study Takanobu UtsumiTakumi EndoHiroyoshi Suzuki Original Article 17 August 2021 Pages: 2295 - 2302
Impact of prostate-specific antigen screening on tumor size in patients with prostate cancer in a super-aging district in Kyoto, Japan Toru MatsugasumiKoji OkiharaOsamu Ukimura Original Article 19 September 2021 Pages: 2303 - 2309
The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study Tomoyuki MakinoTakayuki SakuraiAtsushi Mizokami Original Article 07 September 2021 Pages: 2310 - 2317
Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan Tsuyoshi OhtaSatoru NagaseNobuo Yaegashi Original Article 25 August 2021 Pages: 2318 - 2330
Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer Hidetaka NomuraAi IkkiHiroyuki Kanao Original Article 28 August 2021 Pages: 2331 - 2337
Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients Dai OgataKeiji TaneseNaoya Yamazaki Original Article 21 September 2021 Pages: 2338 - 2346
The cancer‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma Shoulei LiangYong LiBaocang Wang Original Article 21 September 2021 Pages: 2347 - 2354
